title: Utility of Hantzsch reaction for development of highly sensitive spectrofluorimetric method for determination of alfuzosin and terazosin in bulk, dosage forms and human plasma.
abstract: A highly sensitive, cheap, simple and accurate spectrofluorimetric method has been developed and validated for the determination of alfuzosin hydrochloride and terazosin hydrochloride in their pharmaceutical dosage forms and in human plasma. The developed method is based on the reaction of the primary amine moiety in the studied drugs with acetylacetone and formaldehyde according to the Hantzsch reaction, producing yellow fluorescent products that can be measured spectrofluorimetrically at 480 nm after excitation at 415 nm. Different experimental parameters affecting the development and stability of the reaction products were carefully studied and optimized. The fluorescence-concentration plots of alfuzosin and terazosin were rectilinear over a concentration range of 70-900 ng ml-1, with quantitation limits 27.1 and 32.2 ng ml-1for alfuzosin and terazosin, respectively. The proposed method was validated according to ICH guidelines and successfully applied to the analysis of the investigated drugs in dosage forms, content uniformity test and spiked human plasma with high accuracy.
authors.affiliation: Department of Analytical Chemistry, Minia University, Minia, Egypt.
authors.forename: Mohamed A
authors.identifier: http://orcid.org/0000-0003-2091-7660
authors.initials: MA
authors.lastname: Hammad
authors.affiliation: Department of Analytical Chemistry, Minia University, Minia, Egypt.
authors.forename: Mahmoud A
authors.initials: MA
authors.lastname: Omar
authors.affiliation: Department of Pharmaceutical Analytical Chemistry, Al-Azhar University, Assiut, Egypt.
authors.forename: Baher I
authors.initials: BI
authors.lastname: Salman
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000032:analysis* / Q000097:blood; D004304:Dosage Forms; D006801:Humans; D010949:Plasma / Q000737:chemistry; D011224:Prazosin / Q000031:analogs & derivatives* / Q000032:analysis / Q000097:blood; D011799:Quinazolines / Q000032:analysis* / Q000097:blood; D013050:Spectrometry, Fluorescence / Q000379:methods*
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D004304:Dosage Forms; D011799:Quinazolines; C041226:Terazosin; C047638:alfuzosin; D011224:Prazosin
keywords: acetylacetone; alfuzosin; content uniformity testing; human plasma; spectrofluorimetry; terazosin